跳至主要内容
临床试验/CTRI/2018/09/015775
CTRI/2018/09/015775已完成2 期

A randomised, open label, comparative, parallel group, clinical study to evaluate the anti-pyretic efficacy of JRKs NiKu plus with mild fever of recent origin.

Dr JRKs Research and Pharmaceuticals Pvt Ltd0 个研究点目标入组 34 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Proper written informed consent obtained from the patient before any procedure performed.
  • 2.Adults between the age of 18-75 years with an oral temperature of more than 38.0°C (100.4°F)
  • 3.Patient should have not participated in any other clinical trial during the past 3 months.

排除标准

  • 1.History of allergy to any of the drugs in the study
  • 2.Had taken antipyretics within 8 hours
  • 3.Patient who are unable to consume solid and liquid orals.
  • 4.Renal, hepatic or haematological disorders
  • 5.Bronchial asthma, peptic ulcer disease, vomiting
  • 6.Pregnant or lactating women
  • 7.Patients who are unable to sign informed consent.
  • 8.Patient unwilling or unable to comply with study procedure.

研究者

发起方
Dr JRKs Research and Pharmaceuticals Pvt Ltd

相似试验

Effect of NiKu plus in reducing fever. | 临床试验